UFH-001 cells: A novel triple negative, CAIX-positive, human breast cancer model system

References

• Hilvo M, Salzano AM, Innocenti A, Kulomaa MS, Scozzafava A, Scaloni A, Parkkila S, Supuran CT. Cloning, Expression, Post-Translational Modifications and Inhibition Studies on the Latest Mammalian Carbonic Anhydrase Isoform, CA XV. J Med Chem. 2009;52:646–54. doi:10.1021/jm801267c. PMID:19193158.
   PubMed Web of Science ®Google Scholar
• Opavsky R, Pastorekova S, Zeln¡k V, Gibadulinov A, Stanbridge EJ, Z vada J, Kettmann R, Pastorek J. Human MN/CA9 Gene, A Novel Member of the Carbonic Anhydrase Family: Structure and Exon to Protein Domain Relationships. Genomics. 1996;33:480–7. doi:10.1006/geno.1996.0223. PMID:8661007.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang H, Tu C, Shiverick KT, Silverman DN, Frost SC. Role of Hypoxia and EGF on Expression, Activity, Localization, and Phosphorylation of Carbonic Anhydrase IX in MDA-MB-231 Breast Cancer Cells. Biochim Biophy Acta. 2011;1813:159–67. doi:10.1016/j.bbamcr.2010.09.018. PMID:20920536.
   PubMed Web of Science ®Google Scholar
• Hilvo M, Baranauskiene L, Salzano AM, Scaloni A, Matulis D, Innocenti A, Scozzafava A, Monti SM, Di Fiore A, De Simone G, et al. Biochemical Characterization of CA IX, One of the Most Active Carbonic Anhydrase Isozymes. J Biol Chem. 2008;283:27799–809. doi:10.1074/jbc.M800938200. PMID:18703501.
   PubMed Web of Science ®Google Scholar
• Saarnio J, Parkkila S, Parkkila AK, Waheed A, Casey MC, Zhou XY, Pastorekova S, Pastorek J, Karttunen T, Haukipuro K, et al. Immunohistochemistry of Carbonic Anhydrase Isozyme IX (MN/CA IX) in Human Gut Reveals Polarized Expression in Epithelial Cells with the Highest Proliferative Capacity. J Histochem Cytochem. 1998;46:497–504. doi:10.1177/002215549804600409. PMID:9524195.
   PubMed Web of Science ®Google Scholar
• Wykoff CC, Beasley NJP, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, et al. Hypoxia-inducible Expression of Tumor-associated Carbonic Anhydrase. Cancer Res. 2000;60:7075–83. PMID:11156414.
   PubMed Web of Science ®Google Scholar
• Tafreshi NK, Lloyd MC, Proemsey JB, Bui MM, Kim J, Gillies RJ, Morse DL. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia. Mol Imaging Biol. 2016;18(2):219–31. doi:10.1007/s11307-015-0885-x. PMID:26276155.
   PubMed Web of Science ®Google Scholar
• Span PM, Bussink J, Manders P, Beex LVAM, Sweep CGJ. Carbonic Anhydrase-9 Expression Levels and Prognosis in Human Breast Cancer: Association with Treatment Outcome. Br J Cancer. 2003;89:271–6. doi:10.1038/sj.bjc.6601122. PMID:12865916.
   PubMed Web of Science ®Google Scholar
• Generali D, Fox SB, Berruti A, Brizzi MP, Campo L, Bonardi S, Wigfield SM, Bruzzi P, Bersiga A, Allevi G, et al. Role of Carbonic Anhydrase IX Expression in Prediction of the Efficacy and Outcome of Primary Epirubicin/Tamoxifen Therapy for Breast Cancer. Endocrine-Related Cancer. 2006;13:921–30. doi:10.1677/erc.1.01216. PMID:16954440.
   PubMed Web of Science ®Google Scholar
• Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL. Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Cancer. J Clin Oncol. 2001;19:3660–8. doi:10.1200/JCO.2001.19.16.3660.
   PubMed Web of Science ®Google Scholar
• Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK. Acid Production in Glycolysis-impaired Tumors Provides New Insights into Tumor Metabolism. Clin Cancer Res. 2002;8:1284–91.
   PubMed Web of Science ®Google Scholar
• Swietach P, Vaughan-Jones RD, Harris AL. Regulation of Tumor pH and the Role of Carbonic Anhydrase 9. Cancer Metastasis Rev. 2007;26:299–310. doi:10.1007/s10555-007-9064-0. PMID:17415526.
   PubMed Web of Science ®Google Scholar
• Swietach P, Wigfield S, Cobden P, Supuran CT, Harris AL, Vaughan-Jones RD. Tumor-Associated Carbonic Anhydrase 9 Spatially Coordinates Intracellular pH in Three-Dimensional Multicellular Growths. J Biol Chem. 2008;283:20473–83. doi:10.1074/jbc.M801330200. PMID:18482982.
   PubMed Web of Science ®Google Scholar
• Gottlieb RA, Giesing HA, Zhu JY, Engler RL, Babior BM. Cell Acidification in Apoptosis: Granulocyte Cology-stimulating Factor Delays Programed Cell Death in Neutrophils by Up-regulating the Vaculolar H + -ATPase. Proc Natl Acad Sci USA. 1995;92:5965–8. doi:10.1073/pnas.92.13.5965..
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, Gillies RJ. Acid-mediated Tumor Invasion: A Multidisplinary Study. Cancer Res. 2006;66:5216–23. doi:10.1158/0008-5472.CAN-05-4193. PMID:16707446.
   PubMed Web of Science ®Google Scholar
• Goetze K, Walenta S, Ksiazkiewicz M, Kunz-Schughart LA, Mueller-Klieser W. Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int J Oncol. 2011;39(2):453–63. PMID:21617859.
   PubMed Web of Science ®Google Scholar
• Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 2013;73(5):1524–35. doi:10.1158/0008-5472.CAN-12-2796. PMID:23288510.
   PubMed Web of Science ®Google Scholar
• Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, Birnbaum D. How basal are triple-negative breast cancers? Int J Cancer. 2008;123(1):236–40. doi:10.1002/ijc.23518. PMID:18398844.
   PubMed Web of Science ®Google Scholar
• Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, El-Sayed ME, Benhasouna A, Brunet J, Akslen LA, et al. Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes. Clin Cancer Res. 2009;15:2302–10.
   PubMed Web of Science ®Google Scholar
• Peddi PF, Ellis MJ, Ma C. Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy. Internat J Breast Cancer. 2012; 2012, Article ID 217185, 7 pages. doi:10.1155/2012/217185:1-7.
   PubMedGoogle Scholar
• Dent R, Hanna WM, Trudeau M, Rawlinson E, Sun P, Narod SA. Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat. 2009;115(2):423–8. doi:10.1007/s10549-008-0086-2. PMID:18543098.
   PubMed Web of Science ®Google Scholar
• Sorlie T, Perou CM, Tibshirani R, Aas R, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. Gene Expression Patterns of Breast Carcinomas Distinguish Tumor Subclasses with Clinical Implications. Proc Natl Acad Sci USA. 2001;98:10869–74. doi:10.1073/pnas.191367098.
   PubMed Web of Science ®Google Scholar
• Eiermann W, Vallis KA. Locoregional treatments for triple-negative breast cancer. Ann Oncol. 2012;23 Suppl 6:vi30−34. doi:10.1093/annonc/mds192. PMID:23012299.
   PubMedGoogle Scholar
• Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, Juul N, Leong CO, Calogrias D, Buraimoh A, et al. Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2010;28(7):1145–53. doi:10.1200/JCO.2009.22.4725. PMID:20100965.
   PubMed Web of Science ®Google Scholar
• Wahba HA, El-Hadaad HA. Current approaches in treatment of triple-negative breast cancer. Cancer Biol Med. 2015;12(2):106–16. PMID:26175926.
   PubMed Web of Science ®Google Scholar
• Tan EY, Yan M, Campo L, Han C, Takano E, Turley H, Candiloro I, Pezzella F, Gatter KC, Millar EKA, et al. The Key Hypoxia Regulated Gene CAIX is Upregulated in Basal-like Breast Tumours and is Associated with Resistance to Chemotherapy. British Journal of Cancer. 2009;100:405–11. doi:10.1038/sj.bjc.6604844. PMID:19165203.
   PubMed Web of Science ®Google Scholar
• Trastour C, Benizri E, Ettore F, Ramaioli A, Chamorey E, Pouyssegur J, Berra E. HIF-1 alpha and CA IX Staining in Invasive Breast Carcinomas: Prognosis and Treatment Outcome. Int J Cancer. 2007;120:1451–8.
   PubMed Web of Science ®Google Scholar
• Hughes P, Marshall D, Reid Y, Parkes H, Gelber C. The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques. 2007;43(5):575, 577−578, 581-572 passim. doi:10.2144/000112598.
   Web of Science ®Google Scholar
• Li Y, Wang H, Oosterwijk E, Tu C, Shiverick KT, Silverman DN, Frost SC. Expression and Activity of Carbonic Anhydrase IX Is Associated with Metabolic Dysfunction in MDA-MB-231 Breast Cancer Cells. Cancer Investigation. 2009;27:613–23. doi:10.1080/07357900802653464. PMID:19367501.
   PubMed Web of Science ®Google Scholar
• Pastorek J, Pastorekova S, Callebaut I, Mornon JP, Zeln¡k V, Opavsky R, Zat'ovicov M, Liao S, Portetelle D, Stanbridge EJ, et al. Cloning and Characterization of MN, a Human Tumor-associated Protein with a Domain Homologous to Carbonic Anhydrase and a Putative Helix-Loop-Helix DNA Binding Segment. Oncogene. 1994;9:2877–88. PMID:8084592.
   PubMed Web of Science ®Google Scholar
• Zavada J, Zavadova Z, Pastorekova S, Ciampor F, Pastorek J, Zelnik V. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer. 1993;54(2):268–74. doi:10.1002/ijc.2910540218. PMID:8486430.
   PubMed Web of Science ®Google Scholar
• Robertson N, Potter C, Harris AL. Role of Carbonic Anhydrase IX in Human Tumor Cell Growth, Survival, and Invasion. Cancer Res. 2004;64:6160–5. doi:10.1158/0008-5472.CAN-03-2224. PMID:15342400.
   PubMed Web of Science ®Google Scholar
• Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe J, Tong F, et al. A Collection of Breast Cancer Cell Lines for the Study of Functionally Distinct Cancer Subtypes. Cancer Cell. 2006;10:515–27. doi:10.1016/j.ccr.2006.10.008. PMID:17157791.
   PubMed Web of Science ®Google Scholar
• Elsheikh SE, Green AR, Rakha EA, Samaka RM, Ammar AA, Powe D, Reis-Filho JS, Ellis IO. Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer. 2008;99(2):327–34. doi:10.1038/sj.bjc.6604463. PMID:18612310.
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Bando Y, Nagao T, Morimoto M, Takai C, Ohnishi T, Honda J, Moriya T, Izumi K, Takahashi M, et al. Expression of p53, Ki-67, E-cadherin, N-cadherin and TOP2A in triple-negative breast cancer. Anticancer research. 2011;31(6):2389–93. PMID:21737670.
   PubMed Web of Science ®Google Scholar
• Changavi AA, Shashikala A, Ramji AS. Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas. J Lab Physicians. 2015;7(2):79–83. doi:10.4103/0974-2727.163129. PMID:26417156.
   PubMedGoogle Scholar
• Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD. MDA-MB-435 Cells Are Derived from M14 Melanoma Cells – a Loss for Breast Cancer, but a Boon for Melanoma Reseach. Breast Cancer Research and Treatment. 2007;104:13–19. doi:10.1007/s10549-006-9392-8. PMID:17004106.
   PubMed Web of Science ®Google Scholar
• Imbalzano KM, Tatarkova I, Imbalzano AN, Nickerson JA. Increasingly transformed MCF-10A cells have a progressively tumor-like phenotype in three-dimensional basement membrane culture. Cancer Cell Int. 2009;9:7. doi:10.1186/1475-2867-9-7. PMID:19291318.
   PubMed Web of Science ®Google Scholar
• Zandberga E, Zayakin P, Abols A, Pupola D, Trapencieris P, Line A. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells. Cancer Biol Ther. 2017:1–10.
   Web of Science ®Google Scholar
• Jeon M, Han J, Nam SJ, Lee JE, Kim S. STC-1 expression is upregulated through an Akt/NF-kappaB-dependent pathway in triple-negative breast cancer cells. Oncol Rep. 2016;36(3):1717–22. doi:10.3892/or.2016.4972. PMID:27461417.
   PubMed Web of Science ®Google Scholar
• Chang AC, Doherty J, Huschtscha LI, Redvers R, Restall C, Reddel RR, Anderson RL. STC1 expression is associated with tumor growth and metastasis in breast cancer. Clin Exp Metastasis. 2015;32(1):15–27. doi:10.1007/s10585-014-9687-9. PMID:25391215.
   PubMed Web of Science ®Google Scholar
• Qu Y, Han B, Yu Y, Yao W, Bose S, Karlan BY, Giuliano AE, Cui X. Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells. PLoS One. 2015;10(7):e0131285. doi:10.1371/journal.pone.0131285. PMID:26147507.
   PubMed Web of Science ®Google Scholar
• Chen A, Beetham H, Black MA, Priya R, Telford BJ, Guest J, Wiggins GA, Godwin TD, Yap AS, Guilford PJ. E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition. BMC Cancer. 2014;14:552. doi:10.1186/1471-2407-14-552. PMID:25079037.
   PubMed Web of Science ®Google Scholar
• Saha B, Chaiwun B, Imam SS, Tsao-Wei DD, Groshen S, Naritoku WY, Imam SA. Overexpression of E-cadherin protein in metastatic breast cancer cells in bone. Anticancer Res. 2007;27(6B):3903–8. PMID:18225549.
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Thompson EW, Williams ED. Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs. 2007;185(1-3):7–19. doi:10.1159/000101298. PMID:17587803.
   PubMed Web of Science ®Google Scholar
• Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9(4):265–73. doi:10.1038/nrc2620. PMID:19262571.
   PubMed Web of Science ®Google Scholar
• Schneider BP, Winer EP, Foulkes WD, Garber J, Perou jM, Richardson A, Sledge GW, Carey LA. Triple-Negative Breast Cancer: Risk Factors to Potential Targets. Clin Cancer Res. 2008;14:8010–8.
   PubMed Web of Science ®Google Scholar
• Silverman DN, Lindskog S. The Catalytic Mechanism of Carbonic Anhydrase – Implication of a Rate Limiting Protolysis of Water. Acc Chem Res. 1988;21:30–36. doi:10.1021/ar00145a005.
   Web of Science ®Google Scholar
• Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A, Dedhar S, Supuran CT. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem. 2011;54(6):1896–902. doi:10.1021/jm101541x. PMID:21361354.
   PubMed Web of Science ®Google Scholar
• Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, Kyle A, auf dem Keller U, Leung S, Huntsman D, et al. Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors. Cancer Res. 2011;71:3364–76. doi:10.1158/0008-5472.CAN-10-4261. PMID:21415165.
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J. A Novel Quasi-viral Agent, MaTu, is a Two-Component System. Virology. 1992;187:620–6. doi:10.1016/0042-6822(92)90464-Z. PMID:1312272.
   PubMed Web of Science ®Google Scholar
• Markwell MAK, Haas SM, Lieber LL, Tolbert NE. A Modification of the Lowry Procedure to Simplify Protein Determination in Membrane and Lipoprotein Samples. Anal Biochem. 1978;87:206–10. doi:10.1016/0003-2697(78)90586-9. PMID:98070.
   PubMed Web of Science ®Google Scholar